Statistical analysis showed that while the healthy control group did not exhibit significant changes in foxp3 methylation levels post-diet, the HT patients experienced a substantial and significant decrease in foxp3 methylation levels post-diet compared to pre-diet levels (Figure 3). The gene discussed is FOXP3; the disease is hematocrit.